Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05458830
Other study ID # Selftest113
Secondary ID 2021.0443
Status Completed
Phase N/A
First received
Last updated
Start date October 7, 2022
Est. completion date April 1, 2023

Study information

Verified date July 2022
Source 113 Suicide Prevention
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Every month, around four thousand people fill in the anonymous self-test for suicidal thoughts on the website of the Dutch suicide prevention helpline 113 Suicide Prevention. The self-test includes the Suicidal Ideation Attributes Scale (SIDAS) and informs people about the severity of their suicidal thoughts. The vast majority (70%) of people who complete the test score higher than the cut-off point (≥ 21) for severe suicidal thoughts. Despite this, only around 10% of test-takers navigate to the webpage about contacting the helpline. In this study the investigators test an intervention that aims to reduce barriers to contacting the helpline via chat or phone. People with severe suicidal thoughts and little motivation to contact the helpline will be randomly allocated either to a brief Barrier Reduction Intervention (BRI) or care as usual, a plain advisory text. The aim of our study is two-fold: (i) to measure the effectiveness of a brief barrier reduction intervention (BRI) in the self-test motivating people with severe suicidal thoughts to contact the helpline, and (ii) to specifically evaluate the effectiveness of the intervention in increasing service utilisation by high-risk groups for suicide such as men and people of middle age.


Description:

Research suggests that people with suicidal thoughts often do not seek help, making them invisible for preventive measures and targeted support. Anonymous online help can be a low-threshold first step towards professional face-to-face help. In the Netherlands, the suicide prevention organisation '113 Suicide Prevention' provides around-the-clock anonymous support by phone and chat, as well as an online self-help course, self-assessment tests and brief online coaching and therapy. Apart from the homepage, the 'test yourself' page is the most visited section of the helpline's website. Every month, more than 4,000 people fill in the anonymous self-test for suicidal thoughts. This self-test includes the Suicidal Ideation Attributes Scale (SIDAS) and informs the test-taker of the severity of their suicidal thoughts. Although the vast majority of people who complete the test score higher than the cut-off point for severe suicidal thoughts, only approximately 10% of test-takers go on to navigate to the web-page about contacting the helpline. And although due to the anonymity of the helpline's services it is not possible to know if people follow up the advice of contacting the helpline, the difference in demographic distributions between the users of the self-test and the crisis helpline confirms the assumption that a substantial group does not continue using helpline service. While the percentage of men among the self-test users is 40%, it is only around 25% among the users of the helpline. The study is designed as a randomised controlled trial for the anonymous users of an online self-test for suicidal thoughts in which individuals with severe suicidal thoughts and no interest in contacting the helpline will be randomly allocated either to a short barrier reduction intervention (BRI) or receive a general advisory text (care as usual). To minimise the burden on our high-risk and sensitive study population, the investigators aim that it is feasible for the participants to complete the intervention within 10 minutes. The aim of our study is two-fold: (i) to measure the effectiveness of a brief barrier reduction intervention (BRI) in the self-test motivating people with severe suicidal thoughts to contact the helpline, and (ii) to specifically evaluate the effectiveness of the intervention in increasing service utilisation by high-risk groups for suicide such as men and people of middle age.


Recruitment information / eligibility

Status Completed
Enrollment 775
Est. completion date April 1, 2023
Est. primary completion date December 5, 2022
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Exclusion Criteria: - participant is younger than 16 years old. - participant scores below the cut-off point for severe suicidal thoughts (SIDAS score < 21). - participant scores above the cut-off point for severe suicidal thoughts (SIDAS score = 21) and reports being likely to contact the suicide prevention helpline. They will be directly transferred to the contact details of the helpline.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Brief Barrier Reduction Intervention
After selecting a barrier in the barrier survey, participants receive tailored information with the purpose of addressing common concerns and misconceptions about the helpline.
Plain advisory text
Care as usual

Locations

Country Name City State
Netherlands 113 Suicide Prevention Amsterdam

Sponsors (1)

Lead Sponsor Collaborator
113 Suicide Prevention

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other Severity of suicidal thoughts: Suicidal Ideation Attributes Scale (SIDAS) Score on the Suicidal Ideation Attributes Scale (SIDAS). The SIDAS consists of five items on a 10-point scale measuring the frequency of suicidal thoughts, controllability, closeness to attempt, distress and interference with daily activities. Total scores range from 0 to 50, with higher scores indicating more severe suicidal thoughts. Baseline measurement
Other Gender Self-reported gender identity (male/female/other) Baseline measurement
Other Age group Self-reported age group Baseline measurement
Other Receiving treatment for mental health problems Currently receiving treatment for mental health problems (yes/no/on waiting list) Baseline measurement
Other Satisfaction with the self-test Respondents' satisfaction with the self-test (intervention or control condition). 4 point-scale ranging from poor to excellent with higher scores indicating a better outcome. immediately after intervention
Primary The use of a direct link to the helpline The primary outcome measure is the use of a direct link to the helpline after completing the intervention or the control condition (plain advisory text, care as usual). immediately after intervention
Secondary Self-reported likelihood of contacting the helpline Due to the anonymous nature of the helpline, it is not possible to measure if people who do not directly use the link to the helpline, contact the helpline at a later point in time. Therefore, the self-reported likelihood of contacting the helpline (5-point interval scale, ranging from not likely to very likely) is included as a proxy measurement. immediately after intervention
See also
  Status Clinical Trial Phase
Recruiting NCT05334381 - Navigating Mental Health Treatment for Black Youth N/A
Recruiting NCT04653337 - Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression Phase 2
Terminated NCT04254809 - Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts N/A
Recruiting NCT05848089 - Real-time Intervention for Suicide Risk Reduction N/A
Recruiting NCT06322199 - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Completed NCT05280756 - Home-based tDCS for Prevention of Suicidal Ideation N/A
Not yet recruiting NCT06454136 - Pilot Trial of Mobile Technology for Adolescent Suicidality N/A
Completed NCT01944293 - Ketamine for Suicidality in Bipolar Depression Phase 1/Phase 2
Completed NCT02021344 - Mental Health First Aid for College Students N/A
Not yet recruiting NCT04686162 - Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy N/A
Recruiting NCT05377177 - Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI N/A
Completed NCT05580757 - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting NCT05925322 - Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality N/A
Not yet recruiting NCT05427734 - Treating Drivers of Suicide Using Jaspr Health N/A
Recruiting NCT04112368 - Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach Phase 4
Completed NCT04026308 - Written vs Electronic Safety Planning Study N/A
Recruiting NCT05537376 - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness N/A
Not yet recruiting NCT06311591 - Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B N/A
Recruiting NCT05894980 - How to Reduce Suicidal Thoughts and Impulsivity in Depression N/A
Not yet recruiting NCT05860257 - Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction N/A